Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy? | SpringerLink
Update on novel P2Y12 inhibitors: Focus on Prasugrel, Ticagrelor, Cangrelor and Elinogrel
JCM | Free Full-Text | Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor | HTML
Ticagrelor - toward more efficient platelet inhibition and beyon | TCRM
Figure 1 from Ticagrelor--is there need for a new player in the antiplatelet-therapy field? | Semantic Scholar
Prasugrel | Nature Reviews Drug Discovery
Prasugrel - Wikipedia
Ticagrelor: agonising over its mechanisms of action - ppt download
Pathways of prasugrel metabolism. | Download Scientific Diagram
Absorption, metabolism and mechanism of action of prasugrel. After... | Download Scientific Diagram
Absorption, metabolism and mechanism of action of prasugrel. After... | Download Scientific Diagram
Antiplatelet therapy in acute coronary syndrome - Brown - 2017 - Continuing Cardiology Education - Wiley Online Library
Figure 1 from Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy. | Semantic Scholar
Adenosine-Mediated Effects of Ticagrelor: Evidence and Potential Clinical Relevance - ScienceDirect
JCM | Free Full-Text | New Antithrombotic Drugs in Acute Coronary Syndrome | HTML
Bioactivation and mechanism of action of clopidogrel, prasugrel, and... | Download Scientific Diagram
Cardio protective drugs: Antiplatelets therapy
Prasugrel: newest antiplatelet agent and its emerging role in management of acute coronary syndrome and percutaneous coronary intervention | Future Cardiology
Prasugrel in Clinical Practice | NEJM
Molecular mechanistic insights into how Prasugrel attenuates pathogenesis-associated with Myocardial infarction and protects against myocardial dysfunction: Prasugrel (Trade name: Effient, Efient), a drug used to prevent blood clots, decreases IRF3, GM ...
An overview of the mechanism of action of antiplatelet drugs, showing... | Download Scientific Diagram
Antiplatelet therapy—A pharmacologist's perspective - ScienceDirect
How to manage prasugrel and ticagrelor in daily practice - European Journal of Internal Medicine
Ticagrelor: Positive, negative and misunderstood properties as a new antiplatelet agent - Steiner - 2013 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
Pharmacodynamic Properties of Antiplatelet Agents
